34.4mn increased in administrative expenses was because the Company is in an expansion period. In 1H19, the Company’s distribution costs and administrative expenses was THB 494.2mn, increased by THB
for sales staff, traveling and vehicle expense for sales staff, cost of advertisement media for product promotion, compensation paid to Zuellig Pharma Ltd. under the Distribution Agreement and
expense for sales staff, cost of advertisement media for product promotion, compensation paid to Zuellig Pharma Ltd. under the Distribution Agreement and compensation for distribution of the Company’s
expense for sales staff, cost of advertisement media for product promotion, compensation paid to Zuellig Pharma Ltd. under the Distribution Agreement and compensation for distribution of the Company’s
29.79 Distribution costs 0.94 1.14 1.82 1.61 0.88 93.62 Administrative expenses 8.82 10.70 9.81 8.68 0.99 11.22 Profit before finance cost and taxes 9.17 11.13 12.94 11.45 3.77 41.11 Finance Cost 1.45
efficient by closing some distribution channels such as ELEGA showrooms that could not generate income as the target together with terminating the retail shop business (Can Do Thailand) since the end of the
. . . . . . Gross profit . . . . . . Other income . . . . . . Profit before expenses, finance cost and taxes . . . . . . Distribution costs . . . . . . Administrative expenses . . . . . . Profit before finance cost
from last year or 208.95 Baht. This is mainly due to the fact that in 2017, GWM’s revenue streams are mostly from medical product distribution as the hemodialysis solution production plant was still
the Company and its subsidiaries as follows: Thailand Economic Q3/18 review and outlook Thailand economic in the third quarter of 2018 continued to grow from strong expansion of Thailand’s export sector
28.91 19.72 31.27 (0.74) (3.61) Distribution costs 1.42 2.01 1.18 1.87 (0.24) (16.86) Administrative expenses 9.79 13.83 10.34 16.39 0.55 5.62 Profit before finance cost and taxes 9.25 13.07 8.20 13.00